Interspecies Modeling and Prediction of Human Exenatide Pharmacokinetics
Authors:
- 15 November 2012
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 30 (3) , 751-760
Abstract
To develop a model-based approach for interspecies scaling of the preclinical pharmacokinetics of exenatide and to predict concentration-time profiles in humans.Keywords
This publication has 40 references indexed in Scilit:
- Target-Mediated Pharmacokinetic and Pharmacodynamic Model of Exendin-4 in Rats, Monkeys, and HumansDrug Metabolism and Disposition, 2012
- Towards a Better Prediction of Peak Concentration, Volume of Distribution and Half-Life after Oral Drug Administration in Man, Using AllometryClinical Pharmacokinetics, 2011
- Pharmacokinetic and Pharmacodynamic Modeling of Exendin-4 in Type 2 Diabetic Goto-Kakizaki RatsThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Interspecies Scaling of Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Type I InterferonsPharmaceutical Research, 2010
- Mixed‐effects modeling of the interspecies pharmacokinetic scaling of oxytetracyclineJournal of Pharmaceutical Sciences, 2002
- Pharmacokinetic actions of exendin‐4 in the rat: Comparison with glucagon‐like peptide‐1Drug Development Research, 2001
- Characterization of Human and Rat Glucagon-Like Peptide-1 Receptors in the Neurointermediate Lobe: Lack of Coupling to Either Stimulation or Inhibition of Adenylyl CyclaseEndocrinology, 2000
- Fluorescein-Trp 25 -Exendin-4, a Biologically Active Fluorescent Probe for the Human GLP-1 ReceptorPeptides, 1997
- Exendin-4 and exendin-(9–39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7–36)NH2European Journal of Pharmacology: Molecular Pharmacology, 1994
- Animal scale-upJournal of Pharmacokinetics and Biopharmaceutics, 1973